BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28903359)

  • 1. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to
    Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Astolfi A; Catera M; Videira PA; Dall'Olio F
    Oncotarget; 2017 Aug; 8(33):54506-54517. PubMed ID: 28903359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.
    Severino PF; Silva M; Carrascal M; Malagolini N; Chiricolo M; Venturi G; Barbaro Forleo R; Astolfi A; Catera M; Videira PA; Dall'Olio F
    BMC Cancer; 2018 Feb; 18(1):198. PubMed ID: 29454317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.
    Munkley J; Oltean S; Vodák D; Wilson BT; Livermore KE; Zhou Y; Star E; Floros VI; Johannessen B; Knight B; McCullagh P; McGrath J; Crundwell M; Skotheim RI; Robson CN; Leung HY; Harries LW; Rajan P; Mills IG; Elliott DJ
    Oncotarget; 2015 Oct; 6(33):34358-74. PubMed ID: 26452038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.
    Carrascal MA; Severino PF; Guadalupe Cabral M; Silva M; Ferreira JA; Calais F; Quinto H; Pen C; Ligeiro D; Santos LL; Dall'Olio F; Videira PA
    Mol Oncol; 2014 May; 8(3):753-65. PubMed ID: 24656965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).
    Saban MR; Simpson C; Davis C; Wallis G; Knowlton N; Frank MB; Centola M; Gallucci RM; Saban R
    BMC Immunol; 2007 May; 8():6. PubMed ID: 17506885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin.
    Thalmann GN; Sermier A; Rentsch C; Möhrle K; Cecchini MG; Studer UE
    J Urol; 2000 Dec; 164(6):2129-33. PubMed ID: 11061941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacillus Calmette-Guérin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival.
    Rahmat JN; Esuvaranathan K; Mahendran R
    Oncol Lett; 2018 Jun; 15(6):9231-9241. PubMed ID: 29844825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
    J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR3 Down-Regulation is Involved in bacillus Calmette-Guérin Induced Bladder Tumor Growth Inhibition.
    Langle YV; Belgorosky D; Prack McCormick B; Sahores A; Góngora A; Baldi A; Lanari C; Lamb C; Eiján AM
    J Urol; 2016 Jan; 195(1):188-97. PubMed ID: 26144336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
    J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon Cancer.
    Kvorjak M; Ahmed Y; Miller ML; Sriram R; Coronnello C; Hashash JG; Hartman DJ; Telmer CA; Miskov-Zivanov N; Finn OJ; Cascio S
    Cancer Immunol Res; 2020 Feb; 8(2):167-178. PubMed ID: 31831633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
    Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells.
    Kim JH; Kim SJ; Lee KM; Chang IH
    BJU Int; 2013 Oct; 112(6):781-90. PubMed ID: 23819923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer.
    Bunimovich-Mendrazitsky S; Claude Gluckman J; Chaskalovic J
    J Theor Biol; 2011 May; 277(1):27-40. PubMed ID: 21334346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.